Corpus Uteri Carcinoma
Conditions
Keywords
carcinoma, uterus, Not metastatic
Brief summary
Evaluate the toxicities of cervix and corpus uteri carcinomas treatment
Detailed description
Evaluate the toxicities of cervix and corpus uteri carcinomas treatment on sexual function after treatment (radiotherapy and/or surgery)
Interventions
None listed
Sponsors
Centre Oscar Lambret
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Inclusion Criteria: * Patients whose treatment is provided to Centre Oscar Lambret * With a corpus uteri adenocarcinoma, no metastatic, treated by: * Surgery and observation without complementary treatment * Or surgery and adjuvant radiotherapy * Or Surgery and curietherapy of vaginal dome * With a cervix carcinoma, stade IA2 to IIB proximal, treated by : * External radiochemotherapy and curietherapy * Or only surgery * Or pre-surgical curietherapy and surgery * Age \> 18 years
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Toxicities including on sexual function | up to 3 years | According to Lent-Soma, NCICTC-AE v3.0, Franco-Italian Glossary |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Compare the various scales of toxicity | up to 3 years | Compare the various scales of toxicity |
| Study the sexual behavior modifications | up to 3 years | According to a questionnaire and a personal discussion |
| Specify correlation modifications of sexual behavior | up to 3 years | Specify the existence of a correlation between toxicities included modifications and sexual behavior modifications |
Countries
France
Outcome results
None listed